Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Tagged patent prosecution · clear
Are You Properly Corroborating Your In Re Katz Declarations? Every so often a decision comes out of the USPTO's Patent Trial & Appeal Board (PTAB) or the Federal Circuit that has immediate value for patent prosecutors . Last week, in EmeraChem…
The difference between "i.e." (id est, "that is") and "e.g." (exempli gratia, "for example") comes up in patent cases from time to time. While the difference is not always clear to some practitioners, it is clear to…
In a non-precedential opinion in Ali v. Carnegie Institution of Washington, [2016-2320] (April 12, 2017), the Federal Circuit affirmed the dismissal, on grounds of sovereign immunity, of Ali’s lawsuit to be added as a co-inventor on several of…
In Personal Web Technologies, LLC v. Apple, Inc., [2016-1174] (February 14, 2017), the Federal Circuit affirmed the Board’s claim construction but vacated the Board’s obviousness determination because the Board did not adequately support its…
During its August Patent Quality Chat, the USPTO discussed the recently launched Patent Prosecution Pilot Program (P3). The P3 program is a hybrid of the After-final Consideration Pilot (AFCP 2.0), which has been available since 2013, and Pre-Appeal Brief…
Everyone hates driving in traffic. The stop and go. The lurch when you accelerate for a moment, then are forced to slam on your brakes when someone cuts into your lane. It’s uncomfortable, unpleasant and fuel-inefficient, not to mention bad for the…
The America Invents Act (AIA) has significantly changed the processes available for prosecuting and challenging a patent. In this final section, I will outline these changes. I’ll start by describing electronic filing and prioritized examination.…
